ETFChannel.com
OCLS Description — Sonoma Pharmaceuticals Inc

Sonoma Pharmaceuticals is a specialty pharmaceutical company that develops and markets solutions for the treatment of dermatological conditions and tissue care in both humans and animals. Co.'s products include: Celacyn®, a prescription hypochlorous acid based scar management; Ceramax™ Skin Barrier Cream helps manage dry itchy skin, minor skin irritations, rashes, and inflammation; Alevicyn™, a prescription hypochlorous acid based atopic dermatitis; Mondoxyne™, a prescription oral tetracycline antibiotic used for the treatment of certain bacterial infections; Microcyn® or Microdacyn60®, a line of products based on electrically charged oxychlorine small molecules.

Company Name: 
Sonoma Pharmaceuticals Inc
Website: 
www.oculusis.com
Sector: 
Drugs & Pharmaceuticals
Quotes delayed 20 minutes

Email EnvelopeFree OCLS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Strong Buy (4.00 out of 4)
100th percentile
(ranked higher than approx. 100% of all stocks covered)

Analysts Forecast:
OCLS Price Target

Based on data provided by Zacks Investment Research via Quandl.com

ETFs Holding OCLS | Sonoma Pharmaceuticals Inc | ETF Channel | www.ETFChannel.com

Copyright © 2010 - 2024, All Rights Reserved Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.